116 related articles for article (PubMed ID: 3629327)
1. Severe neutropenia due to sustained-release procainamide.
Hoyt RE
South Med J; 1987 Sep; 80(9):1196-7. PubMed ID: 3629327
[TBL] [Abstract][Full Text] [Related]
2. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK
Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250
[No Abstract] [Full Text] [Related]
3. Severe neutropenia associated with sustained-release procainamide.
Ellrodt AG; Murata GH; Riedinger MS; Stewart ME; Mochizuki C; Gray R
Ann Intern Med; 1984 Feb; 100(2):197-201. PubMed ID: 6691661
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release procainamide and neutropenia.
Anderson S; Wenger NK
Ann Intern Med; 1984 Sep; 101(3):404. PubMed ID: 6465719
[No Abstract] [Full Text] [Related]
5. Agranulocytosis due to new sustained-release procainamide.
Berger BE; Hauser DJ
Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
[No Abstract] [Full Text] [Related]
6. Procainamide and neutropenia.
Ann Intern Med; 1984 May; 100(5):766-7. PubMed ID: 6712043
[No Abstract] [Full Text] [Related]
7. Severe neutropenia with procainamide therapy.
Hoffman HS
Conn Med; 1990 Feb; 54(2):59-61. PubMed ID: 2306941
[No Abstract] [Full Text] [Related]
8. Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction.
Abe H; Suzuka H; Tasaki H; Kuroiwa A
Jpn Heart J; 1995 Jul; 36(4):483-7. PubMed ID: 7474364
[TBL] [Abstract][Full Text] [Related]
9. Procainamide-induced agranulocytosis.
Reidy TJ; Upshaw JD
South Med J; 1984 Dec; 77(12):1582-4. PubMed ID: 6505768
[TBL] [Abstract][Full Text] [Related]
10. Bone marrow granulomas and neutropenia associated with procainamide. Report of a case.
Riker J; Baker J; Swanson M
Arch Intern Med; 1978 Nov; 138(11):1731-2. PubMed ID: 718331
[TBL] [Abstract][Full Text] [Related]
11. Neutropenia associated with procainamide.
Kimmel DP; Antignano LV; Barold SS; Boros L; Olson JP
N Y State J Med; 1985 May; 85(5):197. PubMed ID: 3859759
[No Abstract] [Full Text] [Related]
12. Neutropenia and procainamide.
Katkov W; Ellrodt AG
Am Heart J; 1985 Dec; 110(6):1321-2. PubMed ID: 4072899
[No Abstract] [Full Text] [Related]
13. Agranulocytosis secondary to extended-release procainamide: a case report and review of the literature. A case of agranulocytosis caused by procainamide in a patient who had undergone open-heart surgery.
Malters PB; Salem AG
S D J Med; 1987 Feb; 40(2):7-10. PubMed ID: 3470941
[No Abstract] [Full Text] [Related]
14. Agranulocytosis associated with procainamide therapy--report of a case.
Prince RA; Brown BT; Jacknowitz AI
Am J Hosp Pharm; 1977 Dec; 34(12):1362-5. PubMed ID: 596390
[TBL] [Abstract][Full Text] [Related]
15. Correction: procainamide versus Procan SR.
Boros L
N Y State J Med; 1985 Oct; 85(10):611. PubMed ID: 3866171
[No Abstract] [Full Text] [Related]
16. Agranulocytosis, thrombocytopenia, and procainamide.
Christensen DJ; Palma LF; Phelps K
Ann Intern Med; 1984 Jun; 100(6):918. PubMed ID: 6721310
[No Abstract] [Full Text] [Related]
17. Pure red cell aplasia associated with administration of sustained-release procainamide.
Giannone L; Kugler JW; Krantz SB
Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
[TBL] [Abstract][Full Text] [Related]
18. Agranulocytosis following procainamide administration.
Wang RI; Schuller G
Am Heart J; 1969 Aug; 78(2):282-4. PubMed ID: 5797276
[No Abstract] [Full Text] [Related]
19. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
Anderson JL
Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
[TBL] [Abstract][Full Text] [Related]
20. Agranulocytosis in a 12-year-old girl treated with procainamide.
Gunay U; Honig GR
Clin Pediatr (Phila); 1974 Sep; 13(9):728-30. PubMed ID: 4411903
[No Abstract] [Full Text] [Related]
[Next] [New Search]
